Awen Oncology
Awen Oncology is an oncology drug discovery company, targeting rare cancers that currently have no effective treatment options such as chordoma. The company combines structural biology with high throughput in silico drug candidate screening to enable the discovery of a new pipeline of pharmaceuticals.